EPAM
NVO

Euro Pacific Asset Management’s Novo Nordisk NVO Stock Holding History

Euro Pacific Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2M Buy
594,135
+126,683
+27% +$5.44M 2.07% 17
2026
Q1 		$22.4M Buy
467,452
+121,375
+35% +$5.75M 2.22% 16
2025
Q4 		$20.4M Buy
346,077
+67,261
+24% +$3.44M 2.26% 15
2025
Q3 		$17.5M Buy
278,816
+163,386
+142% +$9.56M 2.11% 15
2025
Q2 		$7.97M Buy
115,430
+25,273
+28% +$1.72M 1.29% 26
2025
Q1 		$6.26M Sell
90,157
-1,233
-1% -$102K 1.14% 28
2024
Q4 		$7.99M Sell
91,390
-2,820
-3% -$305K 1.72% 23
2024
Q3 		$11.1M Sell
94,210
-2,152
-2% -$287K 2.05% 23
2024
Q2 		$13.9M Sell
96,362
-2,122
-2% -$281K 2.75% 15
2024
Q1 		$12.6M Sell
98,484
-26,887
-21% -$3.2M 2.56% 18
2023
Q4 		$12.9M Sell
125,371
-2,099
-2% -$208K 2.76% 15
2023
Q3 		$11.6M Sell
127,470
-2,320
-2% -$204K 2.72% 17
2023
Q2 		$10.3M Sell
129,790
-1,508
-1% -$123K 2.26% 22
2023
Q1 		$10.5M Sell
131,298
-3,228
-2% -$229K 2.24% 22
2022
Q4 		$9.21M Sell
134,526
-2,812
-2% -$165K 2.06% 20
2022
Q3 		$6.95M Sell
137,338
-91,224
-40% -$4.89M 1.82% 26
2022
Q2 		$12.6M Sell
228,562
-5,282
-2% -$293K 2.98% 10
2022
Q1 		$13.1M Sell
233,844
-36,172
-13% -$1.86M 2.57% 19
2021
Q4 		$14.4M Sell
270,016
-2,166
-0.8% -$117K 3.24% 6
2021
Q3 		$14.5M Sell
272,182
-10,650
-4% -$515K 3.79% 6
2021
Q2 		$11.8M Buy
282,832
+35,412
+14% +$1.37M 2.89% 14
2021
Q1 		$8.42M Sell
247,420
-7,552
-3% -$269K 2.16% 20
2020
Q4 		$9.04M Buy
254,972
+442
+0.2% +$15.3K 2.19% 20
2020
Q3 		$8.84M Sell
254,530
-978
-0.4% -$32.6K 2.24% 18
2020
Q2 		$8.38M Sell
255,508
-9,098
-3% -$290K 2.34% 18
2020
Q1 		$8.36M Sell
264,606
-53,934
-17% -$1.61M 2.77% 12
2019
Q4 		$9.19M Buy
+318,540
New +$8.82M 3.32% 10

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Euro Pacific Asset Management's NVO Position: Q2 2026 in Review

Euro Pacific Asset Management increased its Novo Nordisk (NVO) stake by 27% in Q2 2026, buying an estimated $5.44M and bringing the position to 594,135 shares worth $18.2M. The position accounts for 2.07% of the portfolio, ranked #17.

Euro Pacific Asset Management first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $22.4M in Q1 2026. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Euro Pacific Asset Management held 594,135 shares of Novo Nordisk worth $18.2M as of Q2 2026.
  • Euro Pacific Asset Management bought 126,683 Novo Nordisk shares in Q2 2026, an estimated $5.44M.
  • Novo Nordisk made up 2.07% of Euro Pacific Asset Management's portfolio in Q2 2026, its #17 holding.
  • Euro Pacific Asset Management first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • Euro Pacific Asset Management's Novo Nordisk position peaked at $22.4M in Q1 2026.
  • 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Euro Pacific Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.